Hepatic transporters, including efflux transporters (ABC family) and uptake transporters (SLC family), have been recognized to play an important role in the disposition of various drugs. These membrane transporters show extensive substrate specificity with an abundant of overlap, implying the probability of transporter involved in the drug-drug interactions (DDIs) with other compounds. Thus reliable techniques are taken to evaluate the role of transporter-mediated drug disposition and possible effects on pharmacokinetics in the research. In the article, we give a summary on the techniques applied to evaluate the drug clearance mediated by hepatic transporters. The function of membrane transporters could be evaluated in vitro, in situ and in vivo, employing models spanning from cell-based assay to transgenic mouse. Each technique has its own application with specific advantages and limitations. In addition, this article focuses particularly on the in vitro-in vivo extrapolation (IVIVE) of hepatic transporter-mediated drug clearance.